KIF3B has been identified as a potential therapeutic target for various cancers, including breast cancer [39], pancreatic cancer [40], cervical cancer [41], and oral squamous cell carcinoma [42]. This evidence concerns the gene KIF3B and familial pancreatic carcinoma.